48 institutions reported holding $38.1M of ACRIVON THERAPEU (ACRV) in SEC 13F filings for 2026-06-30. Largest institutional holders: RA CAPITAL MANAGEMENT, L.P. ($21.8M), Sands Capital Alternatives, LLC ($4.1M), ACADIAN ASSET MANAGEMENT LLC ($2.1M), VANGUARD GROUP INC ($2.0M), WELLINGTON MANAGEMENT GROUP LLP ($1.6M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30